サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1595024

足場技術の世界市場

Scaffold Technology

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
足場技術の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

足場技術の世界市場は2030年までに28億米ドルに達する見込み

2023年に18億米ドルと推定される足場技術の世界市場は、分析期間2023-2030年にCAGR 7.0％で成長し、2030年には28億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるハイドロゲルは、CAGR7.5%を記録し、分析期間終了時には13億米ドルに達すると予測されています。ポリメリック・スキャフォールド（Polymeric Scaffolds）分野の成長率は、分析期間中CAGR 6.0％と推定されます。

米国市場は推定4億8,090万米ドル、中国はCAGR6.5％で成長予測

米国の足場技術市場は、2023年に4億8,090万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを6.5%として、2030年までに4億3,550万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.6%と5.6%と予測されています。欧州では、ドイツがCAGR 5.7%で成長すると予測されています。

世界の足場技術市場- 主要動向と促進要因のまとめ

足場技術は再生医療の新たなフロンティアをどのように開拓しているのか？

足場技術は再生医療の最前線にあり、損傷した組織や病気になった組織の修復において、細胞増殖と組織形成のための重要な枠組みを提供しています。この技術は、生体適合性材料を用いて、足場として機能する3D構造体を作成し、体内での新しい細胞の成長をサポートします。これらの足場は細胞外マトリックスを模倣し、細胞の接着、増殖、新しい組織の形成を促します。組織工学、ドラッグデリバリー、幹細胞研究などに広く応用されており、臓器不足への対応、創傷治癒の促進、複雑な疾患に対するより効果的な治療オプションの創出などが期待されています。

足場技術市場の主要セグメントは？

主要材料には天然、合成、複合の足場があり、それぞれが特定の用途に独自の利点を提供しています。コラーゲンやキトサンなどに由来する天然足場は、生体適合性で支持されているが、合成足場に見られるような構造的強度に欠ける場合があります。ポリ乳酸（PLA）やポリエチレングリコール（PEG）のような合成材料は、強固な構造支持を提供します。一方、複合足場は天然と合成の両方の要素を組み合わせ、生体適合性と強度のバランスを提供します。KEYWORDの用途は、組織工学や再生医療からドラッグデリバリーシステムや幹細胞研究まで多岐にわたる。エンドユーザーには病院、研究機関、バイオ製薬会社などが含まれ、再生医療や組織工学に重点を置く研究機関が大きなシェアを占めています。バイオ製薬会社は、3Dスキャフォールドが従来の2D細胞培養よりも正確なヒト組織モデルを提供することから、薬剤の試験や開発に足場技術を採用するケースが増えています。また、病院や専門クリニックでも、特に創傷治療や再建手術などの臨床現場で足場が使用され始めています。

足場技術は医療分野でどのように応用されていますか？

組織工学において、足場技術は、特に骨、軟骨、皮膚などの損傷した組織を置換、修復する構築物の作成に使用されます。足場はまた、再生医療において幹細胞の成長をサポートするために使用され、変性疾患や臓器修復の治療の可能性を提供します。さらにドラッグデリバリーでは、足場は治療薬の制御放出を可能にし、薬効を向上させ、副作用を軽減します。臨床場面では、創傷治癒に応用され、皮膚組織の再生を促進し、火傷患者や慢性創傷患者の予後を改善します。

足場技術市場の成長を促進する要因は？

足場技術市場の成長は、バイオマテリアルの進歩、再生医療研究の増加、臓器・組織修復ソリューションの需要拡大など、いくつかの要因によって牽引されています。3Dプリンティングとナノテクノロジーの革新は足場技術の用途を拡大し、複雑でカスタマイズされた足場の製造を可能にしました。臓器移植の代替治療法の開発、組織再生の促進、ドラッグデリバリーの強化が注目され、足場技術はこれらの目標に不可欠なサポートを提供するため、需要はさらに高まっています。さらに、再生医療研究への資金提供の増加、バイオテクノロジー企業間の提携、臨床応用の裾野の拡大が市場成長に寄与し、足場技術の幅広い採用を支えています。

セグメント

タイプ（ハイドロゲル、高分子足場、マイクロパターン表面マイクロプレート、ナノファイバーベース足場）、用途（幹細胞治療、再生医療、組織工学、創薬、その他用途）、最終用途（バイオテクノロジー・製薬企業、研究所・研究所、病院・診断センター、その他最終用途）

調査対象企業の例（全34件）

  • 3D Biotek LLC
  • Avacta Life Sciences Limited
  • Becton
  • Corning Inc.
  • Dickinson and Company
  • Marticel GmbH
  • Merck and Company
  • Molecular Matrix Inc.
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Pelo Biotech GmbH
  • ReproCELL Europe Ltd.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22740

Global Scaffold Technology Market to Reach US$2.8 Billion by 2030

The global market for Scaffold Technology estimated at US$1.8 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Polymeric Scaffolds segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$480.9 Million While China is Forecast to Grow at 6.5% CAGR

The Scaffold Technology market in the U.S. is estimated at US$480.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$435.5 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Scaffold Technology Market - Key Trends and Drivers Summarized

How Is Scaffold Technology Pioneering New Frontiers in Regenerative Medicine?

Scaffold technology is at the forefront of regenerative medicine, providing a crucial framework for cell growth and tissue formation in the repair of damaged or diseased tissues. This technology uses biocompatible materials to create 3D structures that act as scaffolds, supporting the growth of new cells in the body. These scaffolds mimic the extracellular matrix, encouraging cells to adhere, proliferate, and form new tissue. Scaffold technology is widely applied in tissue engineering, drug delivery, and stem cell research, as it holds promise for addressing organ shortages, enhancing wound healing, and creating more effective therapeutic options for complex diseases.

What Are the Key Segments in the Scaffold Technology Market?

Key materials include natural, synthetic, and composite scaffolds, each offering unique benefits for specific applications. Natural scaffolds, derived from sources like collagen and chitosan, are favored for their biocompatibility but may lack the structural strength found in synthetic scaffolds. Synthetic materials, such as polylactic acid (PLA) and polyethylene glycol (PEG), provide robust structural support, while composite scaffolds combine both natural and synthetic elements, offering a balance of biocompatibility and strength. Applications of scaffold technology range from tissue engineering and regenerative medicine to drug delivery systems and stem cell research. End-users include hospitals, research institutions, and biopharmaceutical companies, with research institutions holding a significant share due to their focus on regenerative medicine and tissue engineering. Biopharmaceutical companies are increasingly adopting scaffold technology for drug testing and development, as 3D scaffolds provide a more accurate model of human tissue than traditional 2D cell cultures. Hospitals and specialized clinics are also beginning to use scaffolds in clinical settings, particularly for wound care and reconstructive surgeries.

How Is Scaffold Technology Applied Across Medical Fields?

In tissue engineering, scaffold technology is used to create constructs that can replace or repair damaged tissues, particularly in cases of bone, cartilage, and skin injuries. Scaffolds are also used in regenerative medicine to support stem cell growth, offering potential treatments for degenerative diseases and organ repair. Additionally, in drug delivery, scaffolds allow for the controlled release of therapeutic agents, improving drug efficacy and reducing side effects. In clinical settings, scaffold technology is applied in wound healing, where it accelerates the regeneration of skin tissue and improves outcomes for burn victims and chronic wound patients.

What Factors Are Driving the Growth in the Scaffold Technology Market?

The growth in the Scaffold Technology market is driven by several factors, including advancements in biomaterials, increased research in regenerative medicine, and a growing demand for organ and tissue repair solutions. Innovations in 3D printing and nanotechnology have expanded the applications of scaffold technology, enabling the production of complex and customized scaffolds. The focus on developing alternative treatments for organ transplants, accelerating tissue regeneration, and enhancing drug delivery has further fueled demand, as scaffold technology provides essential support for these goals. Additionally, increased funding for regenerative medicine research, partnerships between biotech companies, and an expanding base of clinical applications have contributed to market growth, supporting the broader adoption of scaffold technology.

SCOPE OF STUDY:

The report analyzes the Scaffold Technology market in terms of US$ Thousand by the following Application; End-Use; Type, and Geographic Regions/Countries:

Segments:

Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds); Application (Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery, Other Applications); End-Use (Biotech & Pharma Companies, Research Laboratories & Institutes, Hospitals & Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • 3D Biotek LLC
  • Avacta Life Sciences Limited
  • Becton
  • Corning Inc.
  • Dickinson and Company
  • Marticel GmbH
  • Merck and Company
  • Molecular Matrix Inc.
  • Nanofiber Solutions
  • NuVasive, Inc.
  • Pelo Biotech GmbH
  • ReproCELL Europe Ltd.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Scaffold Technology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Tissue Engineering Propel Scaffold Technology Adoption
    • Rising Demand for 3D-Printed Scaffolds Expands Market Opportunities
    • Increasing Focus on Regenerative Medicine Spurs Growth
    • Improved Biocompatibility in Scaffold Materials Strengthens Business Case
    • Expansion of Scaffold Applications in Drug Discovery Drives Market
    • Emerging Use of Nanotechnology in Scaffold Design Expands Opportunities
    • Advances in Bioengineering Techniques Drive Scaffold Market Growth
    • Increasing Investments in Healthcare R&D Strengthen Market Potential
    • Rising Popularity of Organ Regeneration Supports Scaffold Development
    • Increased Use of Biodegradable Scaffolds Expands Addressable Market
    • Rising Incidence of Chronic Diseases Drives Demand for Scaffolding Technology
    • Development of Novel Biomaterials for Scaffolds Enhances Market Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Scaffold Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Hydrogels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Hydrogels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polymeric Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Polymeric Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Micropatterned Surface Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Micropatterned Surface Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Nanofiber Based Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Nanofiber Based Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World 7-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 16: World 7-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 19: World Scaffold Technology Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: USA 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: USA 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Canada 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Canada 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • JAPAN
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Japan 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Japan 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • CHINA
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: China 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: China 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • EUROPE
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Scaffold Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Scaffold Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • FRANCE
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: France 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • GERMANY
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Germany 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: Italy 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • UNITED KINGDOM
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: UK 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Scaffold Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Scaffold Technology by Type - Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Scaffold Technology by Type - Percentage Breakdown of Value Sales for Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds for the Years 2024 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Scaffold Technology by End-Use - Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 97: Rest of World 7-Year Perspective for Scaffold Technology by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Other End-Uses, Biotech & Pharma Companies and Research Laboratories & Institutes for the Years 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Scaffold Technology by Application - Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World 7-Year Perspective for Scaffold Technology by Application - Percentage Breakdown of Value Sales for Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering, Drug Discovery and Other Applications for the Years 2024 & 2030

IV. COMPETITION